Prenuvo Whole-Body MRI
The full-body MRI scan that became the cocktail-party longevity flex.
The full-body MRI scan that became the longevity cocktail-party flex - and the diagnostic everyone debates.
Prenuvo did something nobody else made commercially viable: a 1-hour full-body MRI with no contrast dye, no radiation, AI-augmented reading, and a price point ($999-2,499) that actually feels accessible compared to traditional medical imaging.
The pitch is screening for early-stage cancers, aneurysms, and structural anomalies before they're symptomatic. The data on whether this actually saves lives in healthy adults is contested - the medical establishment generally argues against it (false positives, anxiety, downstream procedures), and the longevity community generally argues for it (catching things early, peace of mind).
What's genuinely true: it's a thorough scan, the imaging quality is excellent, the report is professionally read, and a real subset of users find meaningful incidentals (often benign, occasionally serious). What's also true: most healthy 35-year-olds will not learn anything actionable. Buy it knowing both.
Buyers with family history of cancer, anyone over 50, those who want imaging-based screening as part of their longevity baseline.
You're prone to anxiety over uncertain findings, or you don't have $1K-2.5K to spend on a screening test.
Specifications
Most often compared with
Where this fits
Prenuvo Whole-Body MRI cross-shops across several editorial surfaces - the full brand catalog, the buyer-intent tags this item carries, the price band it qualifies for, and any execution playbook that uses it.
Prenuvo Whole-Body MRI - buyer FAQ
Is Prenuvo worth $2,499?
Depends on your risk profile. The strongest case is family history of cancer + age 40+ - early-stage cancer detection has meaningful survival impact at that intersection. For healthy adults under 40 with no family history, the medical establishment's standard objection holds: false-positive rates are non-trivial and the downstream procedure cascade (biopsies, follow-up scans) creates real harm in a low-yield population. The longevity-pro buyer typically buys it once for the baseline, then re-scans every 2-3 years.
Prenuvo vs Ezra MRI - which one?
Both whole-body MRI screening, different positioning. Prenuvo runs 1-hour scans at $999-2,499 with broader location coverage (15+ US cities + Canada). Ezra runs slightly faster scans with stronger AI-augmented reads on specific organ systems, similar pricing. Prenuvo has the deeper consumer brand recognition and longer track record. Ezra has the better AI tooling for specific findings. Both are credible.
What does the scan actually find?
Common findings include benign cysts (most kidneys, livers, and ovaries have them), thyroid nodules (>50% of women over 40), and tendon/joint anomalies. Meaningful findings are less common - estimated 1-3% of scans surface a clinically actionable cancer or aneurysm. The trade-off is the downstream cascade of follow-up imaging or biopsies on incidentals that turn out to be benign.
Will my insurance cover it?
No - Prenuvo is cash-pay only. HSA/FSA eligibility varies by plan administrator (some accept it as a "diagnostic" service, others don't). Most buyers treat it as elective healthcare spend. If your insurance offers Health Reimbursement Arrangement (HRA) or Supplemental Insurance Plan benefits, check whether elective screening MRIs qualify before scheduling.
How does Prenuvo compare to Galleri (blood-based cancer screen)?
Different mechanisms entirely. Prenuvo images anatomical structures looking for tumors, aneurysms, or anomalies. Galleri analyzes circulating tumor DNA in blood, looking for cancer signal molecularly. Prenuvo catches localized solid tumors better; Galleri catches certain bloodborne cancers and early-stage signals before they're imageable. Many longevity-pro buyers stack both annually.